Calidi Biotherapeutics announces 1-for-10 reverse stock split effective July 15, 2024

Calidi Biotherapeutics, Inc.

Reverse stock split at a 1-for-10 ratio, effective 12:01 a.m. ET on July 15, 2024.
Stockholder approval obtained at special meeting on June 6, 2024; Board set ratio at 1:10.
No fractional shares will be issued; fractional shares rounded up to the next whole number.
Authorized shares of common stock remain unchanged at 330,000,000 shares.
Trading symbol remains CLDI; new CUSIP number for common stock is 320703309.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.